Australian Institute for Musculoskeletal Science (AIMSS), The University of Melbourne and Western Health, St. Albans, Victoria, Australia.
Department of Medicine, Western Health, The University of Melbourne, St. Albans, Victoria, Australia.
J Gerontol A Biol Sci Med Sci. 2023 Dec 1;78(12):2415-2425. doi: 10.1093/gerona/glad165.
Recent operational definitions of sarcopenia have not been replicated and compared in Australia and New Zealand (ANZ) populations. We aimed to identify sarcopenia measures that discriminate ANZ adults with slow walking speed (<0.8 m/s) and determine the agreement between the Sarcopenia Definitions and Outcomes Consortium (SDOC) and revised European Working Group for Sarcopenia in Older People (EWGSOP2) operational definitions of sarcopenia.
Eight studies comprising 8 100 ANZ community-dwelling adults (mean age ± standard deviation, 62.0 ± 14.4 years) with walking speed, grip strength (GR), and lean mass data were combined. Replicating the SDOC methodology, 15 candidate variables were included in sex-stratified classification and regression tree models and receiver operating characteristic curves on a pooled cohort with complete data to identify variables and cut points discriminating slow walking speed (<0.8 m/s). Agreement and prevalence estimates were compared using Cohen's Kappa (CK).
Receiver operating characteristic curves identified GR as the strongest variable for discriminating slow from normal walking speed in women (GR <20.50 kg, area under curve [AUC] = 0.68) and men (GR <31.05 kg, AUC = 0.64). Near-perfect agreement was found between the derived ANZ cut points and SDOC cut points (CK 0.8-1.0). Sarcopenia prevalence ranged from 1.5% (EWGSOP2) to 37.2% (SDOC) in women and 1.0% (EWGSOP2) to 9.1% (SDOC) in men, with no agreement (CK <0.2) between EWGSOP2 and SDOC.
Grip strength is the primary discriminating characteristic for slow walking speed in ANZ women and men, consistent with findings from the SDOC. Sarcopenia Definitions and Outcomes Consortium and EWGSOP2 definitions showed no agreement suggesting these proposed definitions measure different characteristics and identify people with sarcopenia differently.
最近的肌少症操作定义尚未在澳大利亚和新西兰(ANZ)人群中得到复制和比较。我们旨在确定能够区分 ANZ 成年人(步行速度<0.8m/s)的肌少症测量方法,并确定肌少症定义和结果联合会(SDOC)和修订后的欧洲老年人肌少症工作组(EWGSOP2)肌少症操作定义之间的一致性。
我们将包含 8 项研究的 8100 名 ANZ 社区居住的成年人(平均年龄±标准差,62.0±14.4 岁)的数据进行合并,这些研究包含步行速度、握力(GR)和瘦体重数据。我们采用 SDOC 方法,在包含完整数据的汇总队列中,对 15 种候选变量进行性别分层分类和回归树模型以及受试者工作特征曲线分析,以确定能够区分步行速度较慢(<0.8m/s)的变量和切点。我们使用 Cohen's Kappa(CK)比较一致性和患病率估计值。
受试者工作特征曲线确定 GR 是区分女性(GR<20.50kg,曲线下面积[AUC]=0.68)和男性(GR<31.05kg,AUC=0.64)慢走与正常行走速度的最强变量。从推导得出的 ANZ 切点和 SDOC 切点之间发现了近乎完美的一致性(CK 0.8-1.0)。女性的肌少症患病率从 EWGSOP2 的 1.5%(EWGSOP2)到 SDOC 的 37.2%(SDOC)不等,男性从 EWGSOP2 的 1.0%(EWGSOP2)到 SDOC 的 9.1%(SDOC)不等,而 EWGSOP2 和 SDOC 之间没有一致性(CK<0.2)。
握力是区分 ANZ 男女步行速度较慢的主要特征,这与 SDOC 的研究结果一致。SDOC 和 EWGSOP2 定义之间没有一致性,这表明这些建议的定义测量的是不同的特征,并以不同的方式识别患有肌少症的人。